Results from an HP technology that can “print” drugs will help healthcare providers nationwide answer, “Will this new antibiotic work for my patient?” CDC and HP are collaborating to put new technology in four of CDC’s AR Lab Network regional labs this fall. The inkjet-like printing technology provides rapid susceptibility tests, which indicate if a new drug will or will not work on a patient’s infection.
Too often, hospital laboratories do not have access to susceptibility testing methods for the newest to market antibiotics when they are first available for patient care. 
When hospital laboratories are not able to test a patient sample against the newest antibiotic, healthcare providers do not have the information they need to inform their prescribing and patients may not get an antibiotic that could help them. Therefore, new drugs can be used incorrectly contributing to antimicrobial resistance or underutilized not helping patients in need, leading to side effects or prolonged treatment. This pilot project will help ensure healthcare providers have the latest information to inform their prescribing, the newest drugs last longer, and gold-standard lab results are in healthcare providers’ hands faster. CDC and HP will evaluate the pilot in the four regional laboratories of the AR Lab Network, refine the system, and explore and support a larger rollout of inkjet printing technology in labs nationwide. The first results of this project are expected by early 2019.
When hospital laboratories are not able to test a patient sample against the newest antibiotic, healthcare providers do not have the information they need to inform their prescribing and patients may not get an antibiotic that could help them. Therefore, new drugs can be used incorrectly contributing to antimicrobial resistance or underutilized not helping patients in need, leading to side effects or prolonged treatment. This pilot project will help ensure healthcare providers have the latest information to inform their prescribing, the newest drugs last longer, and gold-standard lab results are in healthcare providers’ hands faster. CDC and HP will evaluate the pilot in the four regional laboratories of the AR Lab Network, refine the system, and explore and support a larger rollout of inkjet printing technology in labs nationwide. The first results of this project are expected by early 2019.
These awards come as part of annual investments by CDC to state and local health departments to enhance the nation’s ability to combat antibiotic resistance. As part of its Antibiotic Resistance Solutions Initiative, CDC invests in state and local health department resources and capacity to combat antibiotic resistance.
Take Action
- Learn more about antibiotic resistance
- Read about HP printer technology
- See how CDC is investing in your state
| CDC’s AR Lab Network helps boost capacity to detect, respond & prevent #AntibioticResistance. New printing technology tests new antibiotics for resistance, allowing healthcare providers to know if specific drugs will work to treat an infection. #CDCfightsAR |  |
.png)
No hay comentarios:
Publicar un comentario